Novartis: all 3,900 studies
Page 24 of 39. Open to participants first (226), then studies with results posted, then the rest; newest registration first within each.
- Time and Motion Study for Ocrelizumab and Ofatumumab Administration in Relapsing Multiple SclerosisCompletedNCT04676555
- Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete ResectionActive, not recruitingNCT04666272
- A First-in-human Study to Investigate the Safety, Tolerability and Pharmacokinetics of MAS825 in Healthy VolunteersCompletedNCT04665154Phase 1
- A Non-interventional Study to Assess the Influence of Automated Optical Coherence Tomography Image Enrichment With Segmentation Information on Disease Activity Assessment in Patients Treated With Licensed Anti- VEGF InjectionsCompletedNCT04662944
- Digital Adherence Monitoring of Inhalative Therapy in Real- Life ConditionsCompletedNCT04656223
- Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged ≥ 12 Years and < 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional TherapiesCompletedNCT04648930
- Evaluating the Safety of Myfortic (Mycophenolate Sodium) in Patients With Lupus NephritisCompletedNCT04645589
- Study to Evaluate the Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 MutationsActive, not recruitingNCT04641442Phase 2
- Open-label Extension Study for CLCZ696G2301 (PARADISE-MI)WithdrawnNCT04637555Phase 3
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema PatientsCompletedNCT04635800Phase 1
- A 52-weeks Observational Study to Evaluate the Safety of Brolucizumab in Patients With nAMDCompletedNCT04632056
- A Worldwide Survey on the Understanding of Psoriatic Disease Among Patients With Psoriasis and Psoriatic ArthritisCompletedNCT04614831
- A First-in-Human Study of CEE321 in Adult SubjectsCompletedNCT04612062Phase 1
- Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate CancerActive, not recruitingNCT04597411Phase 1
- Long Term Special Drug Use-results Surveillance for Mayzent in SPMS PatientsCompletedNCT04593927
- Clevidipine vs Placebo or Standard of Care for Dyspnea and Blood Pressure Control in AHFWithdrawnNCT04592380Phase 3
- Pharmacokinetic Study of Icenticaftor in Participants With Hepatic ImpairmentCompletedNCT04587622Phase 1
- Special Drug Use-results Surveillance of Tabrecta TabletsCompletedNCT04575025
- Atrasentan in Patients With Proteinuric Glomerular DiseasesActive, not recruitingNCT04573920Phase 2
- Atrasentan in Patients With IgA NephropathyActive, not recruitingNCT04573478Phase 3
- Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis ParticipantsCompletedNCT04564053Phase 1
- MAP to Provide Access to Nilotinib, for Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaNo longer availableNCT04559555
- Observational Study for Melanoma Adjuvant Treatment With Tafinlar® + Mekinist® (Dabrafenib + Trametinib)CompletedNCT04547946
- Compassionate Use Program BRAF Mutation-positive Patients in the Adjuvant Treatment of Melanoma After Surgical ResectionNo longer availableNCT04544202
- Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast CancerActive, not recruitingNCT04544189Phase 2
- Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration and Visual Impairment Due to Diabetic Macular EdemaCompletedNCT04543331
- Managed Access Program (MAP) for Patients Diagnosed With Secondary Progressive Multiple Sclerosis With Active DiseaseNo longer availableNCT04540861
- Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear PalsyCompletedNCT04539041Phase 1
- A Study of RGLS4326 in Patients With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT04536688Phase 1
- Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast CancerActive, not recruitingNCT04524000Phase 2
- Nilotinib, for Patients With CML-CP or CML-APNo longer availableNCT04518644
- Study of Efficacy and Safety of Voretigene Neparvovec in Japanese Patients With Biallelic RPE65 Mutation-associated Retinal DystrophyCompletedNCT04516369Phase 3
- Study of Mechanism of Action of Ligelizumab (QGE031) in Patients With Chronic UrticariaTerminatedNCT04513548Phase 1
- Managed Access Program Cohort Treatment Plan CTMT212X2002I to Provide Access to Trametinib and Dabrafenib Combination Therapy for Patients With BRAF V600 Mutation-positive Advanced Non-Small Cell Lung CancerNo longer availableNCT04507919
- MAP to Provide Access to Nilotinib, for Patients With HESNo longer availableNCT04498871
- Compassionate Use Program to Access Trametinib and Dabrafenib for Patients With BRAF Mutation-positive Metastatic MelanomaNo longer availableNCT04489433
- An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal UltrasoundWithdrawnNCT04488185Phase 4
- Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple SclerosisActive, not recruitingNCT04480853Phase 4
- Canakinumab MAP in COVID-19 Pneumonia With CRSNo longer availableNCT04476706
- A Phase II, Open-Label, Multicenter Study of Capmatinib in Subjects With MET Exon 14 Skipping Mutation Positive, Advanced, NSCLC With Brain MetastasesWithdrawnNCT04460729Phase 2
- Study of Tisagenlecleucel in Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-cell Non-Hodgkin Lymphoma (DLBCL)WithdrawnNCT04456023Phase 2
- Study of Safety and Efficacy of Genome-edited Hematopoietic Stem and Progenitor Cells in Sickle Cell Disease (SCD)TerminatedNCT04443907Phase 1
- Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic MelanomaActive, not recruitingNCT04417621Phase 2
- The Purpose of This Study is to Investigate Safety and Tolerability of Tropifexor.CompletedNCT04408937Phase 1
- Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 IllnessNo longer availableNCT04337359
- BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple MyelomaTerminatedNCT04318327Phase 1
- Expanded Access Program for Tafasitamab (MOR00208) in R/R DLBCLApproved for marketingNCT04300803
- A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal CancerTerminatedNCT04294160Phase 1
- Study of Select Combinations in Adults With MyelofibrosisWithdrawnNCT04283526Phase 1
- A Phase I/Ib Study of NIZ985 Alone and in Combination With SpartalizumabTerminatedNCT04261439Phase 1
- Safety and Preliminary Efficacy of JBH492 Monotherapy in Patients With CLL and NHLTerminatedNCT04240704Phase 1
- KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid TumorsTerminatedNCT04237649Early Phase 1
- Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA MutationActive, not recruitingNCT04208178Phase 3
- An Open, Randomised, Single Dose, 2-period, 2-sequence Crossover Adhesion Study of Two Different Transdermal Patches Containing Rotigotine.TerminatedNCT04183634Phase 1
- Study of Tisagenlecleucel in Chinese Pediatric and Young Adult Subjects With Relapsed or Refractory B-cell ALLWithdrawnNCT04156659Phase 2
- Lenalidomide Monotherapy in R/R DLBCLCompletedNCT04150328
- Heart Failure IDentification in a High Risk Cardiovascular OutpatiEnt Population (HIDE)CompletedNCT04143919Not applicable
- A Study of WVT078 in Patients With Multiple Myeloma (MM)TerminatedNCT04123418Phase 1
- Study of Quality of Life in Subjects With Chronic or High-frequency Episodic Migraine and Associated Comorbidities Treated With ErenumabWithdrawnNCT04114630Phase 3
- This Was a Clinical Study Investigating the Moisturization and Desquamation Effect of AmLactin® Rapid Relief Restoring Lotion + Ceramides on Dry Skin in Healthy Female Volunteers. AmLactin® Rapid Relief is an Over-the-counter CosmeticCompletedNCT04085809Not applicable
- Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular EdemaWithdrawnNCT04079231Phase 3
- Safety and Causal Prophylactic Efficacy of KAF156 in a Controlled Human Malaria Challenge ModelCompletedNCT04072302Phase 1
- Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study TreatmentsActive, not recruitingNCT04058756Phase 1
- Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioiActive, not recruitingNCT04042025Phase 3
- Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVDCompletedNCT04023552Phase 3
- Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected MalignanciesTerminatedNCT04000529Phase 1
- Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma.WithdrawnNCT03989635Phase 2
- Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients.WithdrawnNCT03978494Phase 1
- A Functional MRI Study on Erenumab Treatment Effects in Episodic Migraine PatientsCompletedNCT03977649Phase 4
- Pediatric Long-Term Follow-up and Rollover StudyActive, not recruitingNCT03975829Phase 4
- Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCLActive, not recruitingNCT03960840Phase 1/2
- Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)CompletedNCT03945318Phase 1/2
- HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS)TerminatedNCT03940352Phase 1
- Single Dose and Multiple Dose Study to Assess Safety and Tolerability of LOU064CompletedNCT03918980Phase 1
- Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.Active, not recruitingNCT03891953Phase 1
- Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s DiseaseCompletedNCT03890445
- Lipoprotein(a) in Patients With Cardiovascular Disease (CVD)CompletedNCT03887520Not applicable
- Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive PatientsActive, not recruitingNCT03876769Phase 2
- Study of Tisagenlecleucel in Combination With Ibrutinib in r/r Diffuse Large B-cell Lymphoma PatientsTerminatedNCT03876028Phase 1
- A Study of Full Treatment-free Remission in Patients With Chronic Myeloid LeukemiaTerminatedNCT03874858Phase 2
- [177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-neoB Lesion UptakeCompletedNCT03872778Phase 1/2
- Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal CancersCompletedNCT03798626Phase 1
- HDM201 Added to CT in R/R or Newly Diagnosed AMLWithdrawnNCT03760445Phase 1/2
- Study of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC).TerminatedNCT03742349Phase 1
- Managed Access Program to Provide Alpelisib for Patients With HR+ Advanced or Metastatic Breast CancerNo longer availableNCT03706573
- A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast CancerActive, not recruitingNCT03701334Phase 3
- Study to Determine Safety and Dose of NJH395 in Non-breast HER2+ Advanced CancerCompletedNCT03696771Phase 1
- Post-Authorization Long-Term Safety Study of LUTATHERAActive, not recruitingNCT03691064
- Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Healthy Control SubjectsCompletedNCT03681457Phase 1
- Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MSActive, not recruitingNCT03650114Phase 3
- Study of Tisagenlecleucel in Combination With Pembrolizumab in r/r Diffuse Large B-cell Lymphoma PatientsCompletedNCT03630159Phase 1
- Tisagenlecleucel vs Blinatumomab or Inotuzumab for Patients With Relapsed/Refractory B-cell Precursor Acute Lymphoblastic LeukemiaWithdrawnNCT03628053Phase 3
- Pharmacokinetics Study of Asciminib in Subjects With Impaired Renal Function Compared to Matched Healthy VolunteersCompletedNCT03605277Phase 1
- Study of the Effect of Everolimus Immunosuppressive Combination Therapies on Renal Function When Used as a Maintenance Treatment for Liver Transplant Patients.WithdrawnNCT03596970Phase 3
- A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AMLActive, not recruitingNCT03591510Phase 2
- Study Comparing Two VAY736 Drug Products in Patients With Rheumatoid ArthritisCompletedNCT03574545Phase 1
- A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.TerminatedNCT03549000Phase 1
- Study of Loteprednol Etabonate in Adults Undergoing Bilateral Cataract SurgeryCompletedNCT03531697Phase 1
- Phase III Study of Nazartinib (EGF816) Versus Erlotinib/Gefitinib in First-line Locally Advanced / Metastatic NSCLC With EGFR Activating MutationsWithdrawnNCT03529084Phase 3
- 177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate CancerTerminatedNCT03490838Phase 1